Severe darkening of a facial skin graft from latanoprost.
Calladine
Daniel
D
Department of Ophthalmology, Prince Charles Eye Unit, King Edward VII Hospital, Windsor SL4 3DP, England. drdancalladine@doctors.org.uk
Harrison
Rosalind J
RJ
D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects*; D005145:Face; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D000077338:Latanoprost; D008545:Melanoma / Q000601:surgery; D008548:Melanosis / Q000139:chemically induced* / Q000473:pathology; D011461:Prostaglandins F, Synthetic / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000601:surgery; D012880:Skin Pigmentation / Q000187:drug effects*; D016038:Skin Transplantation
D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D000077338:Latanoprost